Mineralys Therapeutics, Inc. — 3 Filings
15 3 filings on record
This page lists all 3 filings submitted to the SEC by Mineralys Therapeutics, Inc. (MLYS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Mineralys Therapeutics, Inc. has filed 15 3 documents with the SEC since 2022. To view all SEC filings by Mineralys Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3ASR
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 3 | FORM 3 | 0001916048-26-000007 | Mar 4, 2026 | — |
| 3 | FORM 3 | 0001933414-24-000030 | Jun 17, 2024 | Jun 13, 2024 |
| 3 | FORM 3 | 0001933414-23-000080 | Sep 14, 2023 | Sep 13, 2023 |
| 3 | FORM 3 | 0001933414-23-000077 | Sep 14, 2023 | Sep 13, 2023 |
| 3 | OWNERSHIP DOCUMENT | 0001104659-23-017791 | Feb 9, 2023 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-23-017740 | Feb 9, 2023 | — |
| 3 | FORM 3 | 0001628280-23-003045 | Feb 9, 2023 | — |
| 3 | FORM 3 | 0001628280-23-003044 | Feb 9, 2023 | — |
| 3 | FORM 3 | 0001628280-23-003043 | Feb 9, 2023 | — |
| 3 | FORM 3 | 0001628280-23-003042 | Feb 9, 2023 | — |
| 3 | FORM 3 | 0001628280-23-003041 | Feb 9, 2023 | — |
| 3 | FORM 3 | 0001628280-23-003040 | Feb 9, 2023 | — |
| 3 | FORM 3 | 0001628280-23-003039 | Feb 9, 2023 | — |
| 3 | FORM 3 | 0001628280-23-003038 | Feb 9, 2023 | — |
| 3 | FORM 3 | 0001628280-23-003037 | Feb 9, 2023 | — |